Search research articles
Contact Us
Filters
Showing results (1-10 of 156) with videos related to
Page
of 16
Sort By:
Cancer Research
|
November 19, 2004
SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival
Yi Zhan, Donald M O'Rourke
Pharmacology & Therapeutics
|
October 20, 2019
Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
Stephen J Bagley, Donald M O'Rourke
Cancer Biology & Therapy
|
September 26, 2003
Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches
Gurpreet S Kapoor, Donald M O'Rourke
Neurosurgery
|
May 24, 2003
Mitogenic signaling cascades in glial tumors
Gurpreet S Kapoor, Donald M O'Rourke
Cancer Research
|
March 5, 2022
Glioblastoma: The Current State of Biology and Therapeutic Strategies
Zev A Binder, Donald M O'Rourke
Cancer Research
|
September 18, 2004
Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling
Gurpreet S Kapoor, Dmitri Kapitonov, Donald M O'Rourke
Cancer Biology & Therapy
|
April 26, 2007
EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53
Gurpreet S Kapoor, Antoire Christie, Donald M O'Rourke
Experimental Cell Research
|
May 12, 2009
The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells
Yi Zhan, George J Counelis, Donald M O'Rourke
Neurosurgery Clinics of North America
|
March 30, 2021
CAR T Cells
Thilan Tudor, Zev A Binder, Donald M O'Rourke
The Journal of Targeted Therapies in Cancer
|
November 24, 2017
Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma
Bryan D Choi, Donald M O'Rourke, Marcela V Maus
Page
of 16
Search research articles
Search
Showing results (1-10 of 156) with videos related to
Sort By:
Page
of 16
Cancer Research
|
November 19, 2004
SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival
Yi Zhan, Donald M O'Rourke
Pharmacology & Therapeutics
|
October 20, 2019
Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
Stephen J Bagley, Donald M O'Rourke
Cancer Biology & Therapy
|
September 26, 2003
Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches
Gurpreet S Kapoor, Donald M O'Rourke
Neurosurgery
|
May 24, 2003
Mitogenic signaling cascades in glial tumors
Gurpreet S Kapoor, Donald M O'Rourke
Cancer Research
|
March 5, 2022
Glioblastoma: The Current State of Biology and Therapeutic Strategies
Zev A Binder, Donald M O'Rourke
Cancer Research
|
September 18, 2004
Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling
Gurpreet S Kapoor, Dmitri Kapitonov, Donald M O'Rourke
Cancer Biology & Therapy
|
April 26, 2007
EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53
Gurpreet S Kapoor, Antoire Christie, Donald M O'Rourke
Experimental Cell Research
|
May 12, 2009
The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells
Yi Zhan, George J Counelis, Donald M O'Rourke
Neurosurgery Clinics of North America
|
March 30, 2021
CAR T Cells
Thilan Tudor, Zev A Binder, Donald M O'Rourke
The Journal of Targeted Therapies in Cancer
|
November 24, 2017
Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma
Bryan D Choi, Donald M O'Rourke, Marcela V Maus
Page
of 16